Last reviewed · How we verify

SPECT MPI — Competitive Intelligence Brief

SPECT MPI (SPECT MPI) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Diagnostic radiopharmaceutical. Area: Cardiovascular.

phase 3 Diagnostic radiopharmaceutical Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

SPECT MPI (SPECT MPI) — GE Healthcare. SPECT MPI is a diagnostic imaging agent that uses technetium-99m labeled tracers to visualize myocardial perfusion and detect areas of reduced blood flow in the heart.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
SPECT MPI TARGET SPECT MPI GE Healthcare phase 3 Diagnostic radiopharmaceutical

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Diagnostic radiopharmaceutical class)

  1. GE Healthcare · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). SPECT MPI — Competitive Intelligence Brief. https://druglandscape.com/ci/spect-mpi. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: